HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhengxiang He Selected Research

Inflammatory Bowel Diseases (Inflammatory Bowel Disease)

11/2018Interleukin 33 regulates gene expression in intestinal epithelial cells independently of its nuclear localization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhengxiang He Research Topics

Disease

5Neoplasms (Cancer)
11/2018 - 03/2010
5Malaria
12/2011 - 07/2008
4Inflammation (Inflammations)
01/2020 - 11/2018
3Colitis
01/2022 - 10/2018
2Infections
01/2020 - 01/2011
2Polyps
12/2019 - 01/2017
2Lung Neoplasms (Lung Cancer)
01/2011 - 12/2010
1Nasopharyngeal Carcinoma
01/2021
1Parakeratosis
01/2020
1Psoriatic Arthritis
01/2020
1Skin Diseases (Skin Disease)
01/2020
1Joint Diseases (Joint Disease)
01/2020
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020
1Necrotizing Enterocolitis
10/2019
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2017
1Carcinogenesis
01/2017
1Ulcerative Colitis
01/2017
1Colonic Neoplasms (Colon Cancer)
01/2017
1Perinatal Death
03/2015
1Hemorrhage
03/2015
1Parasitic Diseases (Parasitic Disease)
01/2011

Drug/Important Bio-Agent (IBA)

5Interleukin-23 (Interleukin 23)IBA
01/2022 - 10/2018
3InterleukinsIBA
01/2022 - 01/2017
3Interleukin-33IBA
01/2020 - 01/2017
3EnzymesIBA
10/2019 - 10/2009
3Protease Inhibitors (Protease Inhibitor)IBA
12/2011 - 07/2008
3Chloroquine (Aralen)FDA LinkGeneric
12/2011 - 07/2008
2Food Coloring AgentsIBA
01/2022 - 01/2021
2Interleukin-22 (IL-22)IBA
01/2020 - 10/2019
2Indinavir (Crixivan)FDA Link
12/2011 - 12/2010
2HIV Protease InhibitorsIBA
12/2010 - 02/2010
1Azo CompoundsIBA
01/2021
1SodiumIBA
01/2021
1SaltsIBA
01/2021
1yellow 6IBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
12/2019
1Diphtheria ToxinIBA
12/2019
1Epidermal Growth Factor (EGF)IBA
12/2019
1Heparin (Liquaemin)FDA LinkGeneric
12/2019
1LigandsIBA
12/2019
1RNA (Ribonucleic Acid)IBA
12/2019
1Matrix Metalloproteinases (MMPs)IBA
12/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2019
1Metalloproteases (Metalloproteinases)IBA
12/2019
1Interleukin-1beta (Interleukin 1 beta)IBA
12/2019
1Neutralizing AntibodiesIBA
12/2019
1Matrix Metalloproteinase InhibitorsIBA
12/2019
1Proteins (Proteins, Gene)FDA Link
10/2019
1LipidsIBA
10/2019
1CarbohydratesIBA
10/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
1Antimicrobial PeptidesIBA
01/2017
11,4- dihydro- 1- ethyl- 7- phenylpyrrol(1,2- a)- pyrimidine- 4- oneIBA
01/2017
1Cell Adhesion MoleculesIBA
03/2015
1DNA VaccinesIBA
01/2011
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2011
1VaccinesIBA
01/2011
1CytokinesIBA
01/2011
1CH05-10IBA
12/2010
1Biological ProductsIBA
03/2010
1Complex MixturesIBA
03/2010
1artemisinin (artemisinine)IBA
02/2010
1Pharmaceutical PreparationsIBA
10/2009
1Antimalarials (Antimalarial Agents)IBA
10/2009
1Glutathione (Reduced Glutathione)IBA
10/2009

Therapy/Procedure

2Therapeutics
01/2011 - 02/2010